LIQUID FACELIFT

Botox® has been used therapeutically for more than 17 years to treat a variety of medical conditions. It is approved in more than 75 countries and remains the most-studied botulinum toxin and one of the most widely researched medicines in the world. In 2002, the same formulation – under the label Botox® Cosmetic – was approved by the US Food and Drug Administration (FDA) for treatment of moderate to severe frown lines between the brows in people ages 18 to 65.

During treatment, very low doses of Botox® Cosmetic are administered via a few tiny injections directly into the muscles responsible for frown lines between the brows. By blocking the release of a chemical that causes these muscles to contract, Botox® Cosmetic enables them to relax. The effects are very localized and, when administered by an experienced physician, do not affect your ability to smile, laugh, or otherwise show expression. Botox® Cosmetic is the only product of its kind that has been approved for use in this area.